Last reviewed · How we verify
NCT03095183
Do Traditional or Flavored Tongue Depressors Make for Easier Posterior Oropharynx Exams in Pediatric Patients
NA trial testing Grape flavored Puritan Junior tongue depressor in Oropharynx in 96 participants. Completed in 21 February 2017.
21 February 2017
Quick facts
| Lead sponsor | Brooke Army Medical Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | device feasibility |
| Enrollment | 96 |
| Start date | 24 August 2016 |
| Primary completion | 21 February 2017 |
| Estimated completion | 21 February 2017 |
Drugs / interventions tested
- Grape flavored Puritan Junior tongue depressor
- Traditional unflavored Puritan Regular Tongue Depressor
Conditions studied
- Oropharynx — all drugs for Oropharynx →
Sponsor
Brooke Army Medical Center
Who can join
Adults 3 to 12, any sex, with Oropharynx. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Evaluation of the oropharynx is a standard component of a general medical exam for all pediatric patients, but is an essential exam in the undifferentiated ill child. Pediatric patients are unable to verbalize where they hurt, and a comprehensive evaluation is needed to identify the source of fever and illness. Frequently, illnesses will present atypically as well, and a patient complaining of abdominal pain may ultimately be diagnosed with streptococcus pharyngitis. If the examiner does not evaluate the posterior oropharynx, the throat as a cause of abdominal pain is easily overlooked. Additionally, young children are prone to infections with pox viruses causing herpangina, hand foot and mouth disease, oral thrush. Despite the importance of the posterior oropharynx exam, it can be a source of stress and anxiety for both the clinician and pediatric patient when a tongue depressor is used to evaluate the posterior oropharynx. However, there are no studies to date that have looked at decreasing the difficulty or at decreasing the perceived discomfort associated with the poster oropharynx exam in the pediatric patient when a tongue depressor is utilized. Despite this paucity of research, there are multiple different flavored and candied tongue depressors available for this purpose which may or may not aid in obtaining posterior oropharynx exam and decrease the discomfort experienced by the patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03095183
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Oropharynx
Currently open trials in the same condition.
- NCT06223568 — Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subject · Phase 2 · recruiting
Other Brooke Army Medical Center trials
Trials by the same sponsor.
- NCT06940986 — The PROmoting Pain Self-Management (PROs) Trial: Holistic Pain Care in the Military Health System · NA · not yet recruiting
- NCT06699901 — Antibiotic Concentrations After MassivE Transfusion Study · recruiting
- NCT06602375 — The Effect of Manual Physical Therapy and Exercise in Addition to Routine Dental Care in Individuals With Temporomandibu · NA · recruiting
- NCT06560190 — Orthopaedic Manual Physical Therapy as Part of the Postpartum Care Continuum · NA · recruiting
- NCT06369701 — Effects Compressive Tissue Flossing on Lateral Elbow Tendinopathy in US Service Members · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03095183 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Brooke Army Medical Center
- Last refreshed: 29 March 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03095183.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing